Log in to save to my catalogue

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iod...

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iod...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_26108532

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS

About this item

Full title

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS

Publisher

Germany

Journal title

Analytical and bioanalytical chemistry, 2015-09, Vol.407 (22), p.6697

Language

English

Formats

Publication information

Publisher

Germany

More information

Scope and Contents

Contents

25I-NBOMe, a new psychoactive substance, is a potent 5-HT2A receptor agonist with strong hallucinogenic potential. Recently, it was involved in several fatal and non-fatal intoxication cases. The aim of the present work was to study its phase I and II metabolism and its detectability in urine screening approaches. After application of 25I-NBOMe to...

Alternative Titles

Full title

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_26108532

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_26108532

Other Identifiers

E-ISSN

1618-2650

DOI

10.1007/s00216-015-8828-6

How to access this item